oalib

OALib Journal期刊

ISSN: 2333-9721

费用:99美元

投稿

匹配条件: “Pistelli” ,找到相关结果约18条。
列表显示的所有文章,均可免费获取
第1页/共18条
每页显示
Speculative Currency Attacks: Role of Inconsistent Macroeconomic Policies and Real Exchange Rate Overvaluation
Alfredo Pistelli
Revista de Análisis Económico (RAE) , 2007,
Abstract: This paper provides a critical analysis of Kaminsky and Reinhart (1999) (KR), perhaps the most prominent empirical paper on causes of currency crises. After dealing with problems present in this paper, it proposes an aggregate leading indicator of crisis. The proposed indicator performs better than a composite index based on the best six individual indicators of KR, both in terms of accuracy and predictive capacity, and represents a unified version of the currency crises approach that emphasizes the role of inconsistent macroeconomic policies as an explanation of currency crises, and the approach that emphasizes the role of tradeoffs among policymakers decisions as the main cause of these crises. Variables included in the proposed leading indicator are: the deviation of the actual stock of international reserves from an estimated demand for international reserves; the real growth of domestic credit; the ratio of domestic credit to M2; and the behavior of both the real exchange rate and industrial production as a measure of overvaluation of the real exchange rate.
Una BOA per i prodotti della ricerca in Bicocca
Bonaria Biancu,Maria Grazia Pistelli
Bollettino del CILEA , 2009, DOI: 10.1472/bc.v0i112.1434
Abstract: BOA is the Milano-Bicocca University repository carried out in the context of the SURplus project in June 2008 in order to place in archives the whole scientific production of the University. With BOA the University aims at creating a complete and inter-workable database of all its scientific publications, a database from which it is possible to feed the remaining SURplus modules, to get consultation and bibliographic citations statistics, to extract information to insert into other databases. BOA (Bicocca Open Archive) è il repository dell'Università di Milano-Bicocca per l'archiviazione della produzione scientifica di Ateneo, creato nell'ambito del progetto SURplus nel giugno 2008. Con BOA l'Università si propone di creare una banca dati omnicomprensiva e interoperabile di tutte le pubblicazioni dell'Università di Milano-Bicocca, dalla quale sia possibile alimentare gli altri moduli di SURplus, ricavare statistiche di consultazione e citazioni bibliografiche ed estrarre informazioni da caricare su altre banche dati.
Tobacco smoking: why do physicians not make diagnoses?
F. Cosci,F. Pistelli,L. Carrozzi
European Respiratory Review , 2011,
Abstract:
Il passaggio dalla versione 14.1 alla versione 16.2 di Aleph500
Rosalba Galloni,Elena Fasola,Maria Grazia Pistelli
Bollettino del CILEA , 2005, DOI: 10.1472/bc.v97igiugno.1185
Abstract: Vengono descritti i problemi incontrati nel passaggio alla release 16.2 di Aleph da diversi punti di vista: il punto di vista delle Università utenti, il punto di vista del System Librarian e il purnto di vista sistemistico. We want to describe the problems arising with Aleph 16.2 release from different points of view: the one of University users, that of System Librarian and that of system administrator.
Nicotine dependence and psychological distress: outcomes and clinical implications in smoking cessation
Cosci F, Pistelli F, Lazzarini N, Carrozzi L
Psychology Research and Behavior Management , 2011, DOI: http://dx.doi.org/10.2147/PRBM.S14243
Abstract: otine dependence and psychological distress: outcomes and clinical implications in smoking cessation Review (3881) Total Article Views Authors: Cosci F, Pistelli F, Lazzarini N, Carrozzi L Published Date September 2011 Volume 2011:4 Pages 119 - 128 DOI: http://dx.doi.org/10.2147/PRBM.S14243 Fiammetta Cosci1, Francesco Pistelli2, Nicola Lazzarini1, Laura Carrozzi2 1Department of Psychology, University of Florence, Florence; 2University Unit of Pulmonology and Respiratory Pathophysiology, Cardiothoracic Department, University Hospital of Pisa, Pisa, Italy Abstract: Nicotine dependence is characteristically a chronic and relapsing disease. Although 75%–85% of smokers would like to quit, and one-third make at least three serious lifetime attempts, less than 50% of smokers succeed in stopping before the age of 60. Relevant and complex factors contributing to sustained cigarette consumption, and strongly implicated in the clinical management of smokers, are the level of nicotine dependence and psychological distress. In this review of the literature, these two factors will be examined in detail to show how they may affect smoking cessation outcome and to encourage clinicians to assess patients so they can offer tailored support in quitting smoking.
Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer
Rossana Berardi, Azzurra Onofri, Mirco Pistelli, et al
Core Evidence , 2010, DOI: http://dx.doi.org/10.2147/CE.S7035
Abstract: nitumumab: the evidence for its use in the treatment of metastatic colorectal cancer Review (2813) Total Article Views Authors: Rossana Berardi, Azzurra Onofri, Mirco Pistelli, et al Published Date September 2010 Volume 2010:5 Pages 61 - 76 DOI: http://dx.doi.org/10.2147/CE.S7035 Rossana Berardi1, Azzurra Onofri2, Mirco Pistelli2, Elena Maccaroni2, Mario Scartozzi1, Chiara Pierantoni1, Stefano Cascinu1 1Clinica di Oncologia Medica, Università Politecnica delle Marche, Ospedali Riuniti Umberto I-GM Lancisi-G Salesi di Ancona, Italy; 2Scuola di Specializzazione in Oncologia Medica, Università Politecnica delle Marche, Ancona, Italy Abstract: Panitumumab is the first fully human monoclonal antibody to Epidermal Growth Factor Receptor (EGFR) to enter clinical trials for the treatment of solid tumors. The anti-tumor activity of panitumumab has been tested in vitro and in vivo, and inhibition of tumor growth has been observed in numerous cancer models, particularly lung, kidney and colorectal (CRC). Preclinical and clinical studies have established a role for panitumumab in metastatic colorectal cancer (mCRC) refractory to multiple chemotherapeutic regimens. Based on these encouraging findings, panitumumab was approved by the US Food and Drug Administration for the treatment of patients with epidermal growth factor receptor-expressing mCRC refractory to fluoropyrimidine-, oxaliplatin-, and/or irinotecan-containing chemotherapeutic regimens. The improvement in progression free survival (PFS) and response rate (RR) produced by panitumumab monotherapy was significantly greater in patients with non mutated (wild-type) K-RAS than in those with mutant K-RAS. Therefore implementing routine K-RAS screening and limiting the use of EGFR inhibitors to patients with wild-type K-RAS appears the better strategy for select only the patients who could benefit from the therapy with panitumumab and also may have the potential for cost savings. The purpose of this review was to evaluate the patient-related, disease-related and economic-related evidence for the use of panitumumab in the treatment of metastatic colorectal cancer in clinical practice.
Nicotine dependence and psychological distress: outcomes and clinical implications in smoking cessation
Cosci F,Pistelli F,Lazzarini N,Carrozzi L
Psychology Research and Behavior Management , 2011,
Abstract: Fiammetta Cosci1, Francesco Pistelli2, Nicola Lazzarini1, Laura Carrozzi21Department of Psychology, University of Florence, Florence; 2University Unit of Pulmonology and Respiratory Pathophysiology, Cardiothoracic Department, University Hospital of Pisa, Pisa, ItalyAbstract: Nicotine dependence is characteristically a chronic and relapsing disease. Although 75%–85% of smokers would like to quit, and one-third make at least three serious lifetime attempts, less than 50% of smokers succeed in stopping before the age of 60. Relevant and complex factors contributing to sustained cigarette consumption, and strongly implicated in the clinical management of smokers, are the level of nicotine dependence and psychological distress. In this review of the literature, these two factors will be examined in detail to show how they may affect smoking cessation outcome and to encourage clinicians to assess patients so they can offer tailored support in quitting smoking.Keywords: nicotine dependence, psychological distress, quitting, smoking cessation, clinical management
Aceite de pescado
Diego Pistelli,Lorena Bertone,Melina Bianchi,Natalia Lopresti
Invenio , 2002,
Abstract:
Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer
Rossana Berardi,Azzurra Onofri,Mirco Pistelli,et al
Core Evidence , 2010,
Abstract: Rossana Berardi1, Azzurra Onofri2, Mirco Pistelli2, Elena Maccaroni2, Mario Scartozzi1, Chiara Pierantoni1, Stefano Cascinu11Clinica di Oncologia Medica, Università Politecnica delle Marche, Ospedali Riuniti Umberto I-GM Lancisi-G Salesi di Ancona, Italy; 2Scuola di Specializzazione in Oncologia Medica, Università Politecnica delle Marche, Ancona, ItalyAbstract: Panitumumab is the first fully human monoclonal antibody to Epidermal Growth Factor Receptor (EGFR) to enter clinical trials for the treatment of solid tumors. The anti-tumor activity of panitumumab has been tested in vitro and in vivo, and inhibition of tumor growth has been observed in numerous cancer models, particularly lung, kidney and colorectal (CRC). Preclinical and clinical studies have established a role for panitumumab in metastatic colorectal cancer (mCRC) refractory to multiple chemotherapeutic regimens. Based on these encouraging findings, panitumumab was approved by the US Food and Drug Administration for the treatment of patients with epidermal growth factor receptor-expressing mCRC refractory to fluoropyrimidine-, oxaliplatin-, and/or irinotecan-containing chemotherapeutic regimens. The improvement in progression free survival (PFS) and response rate (RR) produced by panitumumab monotherapy was significantly greater in patients with non mutated (wild-type) K-RAS than in those with mutant K-RAS. Therefore implementing routine K-RAS screening and limiting the use of EGFR inhibitors to patients with wild-type K-RAS appears the better strategy for select only the patients who could benefit from the therapy with panitumumab and also may have the potential for cost savings. The purpose of this review was to evaluate the patient-related, disease-related and economic-related evidence for the use of panitumumab in the treatment of metastatic colorectal cancer in clinical practice.Keywords: colorectal cancer, EGFR; K-RAS, panitumumab
Monitoramento microbiológico seqüencial da secre??o traqueal em pacientes intubados internados em unidade de terapia intensiva pediátrica
Carvalho, Cid E.;Berezin, Eitan N.;Pistelli, Ivan P.;Mímica, Lycia;Cardoso, Maria Regina A.;
Jornal de Pediatria , 2005, DOI: 10.1590/S0021-75572005000100007
Abstract: objective: to evaluate, sequentially, tracheal aspirates from patients admitted to a pediatric intensive care unit and to associate these pathogens with length of hospital stay, previous use of antimicrobial therapy and diagnoses of ventilator-associated pneumonia. methods: the study population consisted of patients admitted to a pediatric intensive care unit, between november 2002 and december 2003, on ventilator support. three tracheal aspirates were collected serially from each patient. the first tracheal aspirate sample was obtained 6 hours after admission to the intensive care unit and the remaining samples were collected after 48 and 96 hours. results: one hundred patients aged from one day to 14 years were assessed. positive tracheal cultures were observed to have increased in the three tracheal aspirate samples collected from each patient for pseudomonas aeruginosa, from 6 to 22% (p = 0.002), and to have decreased for staphylococcus aureus, from 23 to 8% (p = 0.009). isolation of candida spp increased for the subset that had received previous antimicrobial therapy (p < 0,05). sixteen (23,5%) out of 68 patients admitted without pneumonia developed ventilator-associated pneumonia. positive tracheal aspirate cultures were obtained in 10 out of 16 of these patients: six were positive for staphylococcus aureus (three associated with acinetobacter baumanii), two for klebsiella spp (one associated with enterobacter spp), one for pseudomonas aeruginosa and one for candida spp. conclusion: sequential evaluation of tracheal aspirates may be useful to track changes in bacterial flora at pediatric intensive care units.
第1页/共18条
每页显示


Home
Copyright © 2008-2017 Open Access Library. All rights reserved.